Welcome to Medifit Newsroom. You will get all the important and useful information regarding our products right here. If you don't find what you are looking for, or if we can further assist you, please send an email directly to Medifit Instruments. We will contact you within 24 hours.
 
Apr 4, 2007

Medfit Medifit Instruments Limited, the world leading company in the measurement of Cardiac Vagal Tone and non-invasive Brainstem Assessment, Presents the " One Stop Cardio-Vascular Monitoring " solution for Veterinary Surgeons.
   
Oct 9, 2006

Medfit announces the successful installation of a second NeuroScopeT for gastroenterology research at Hope Hospital, Salford
 
   
Sep 15, 2004

NeuroScopeT leads the way in understanding disease mechanism in Autism
 
 
Aug 27, 2004

Medifit Instruments Ltd brings 21st Century Tele-monitoring to Gulu Independent Hospital in Northern Uganda
 

July 23, 2004

The children’s Hospital at Westmead, Sydney, Australia buys the NeuroScope™ system for innovative research into the Central Autonomic System Function

 
May 29, 2000

The NeuroScope™ system was used by scientist to discover that sheep dips
damages brain at low levels
 
   

 

 
Carolyn Ellaway, Ph.D., The Children's Hospital at Westmead,
Sydney, Australia
"Assessment of Central Autonomic Nervous System Function in Rett Syndrome"

2-Year Award: $88,000
   

The children’s Hospital at Westmead, Sydney, Australia buys the NeuroScope™ system for innovative research into the Central Autonomic System Function
- July 23, 2004

The future of Rett syndrome research will be directed towards understanding the underlying pathogenesis of the disorder and the development of specific treatments, ideally prior to the onset of symptoms or early in the evolution of the disorder. It is therefore vitally important to establish objective methods for assessment of the clinical status of patients with Rett syndrome, prior to commencement of clinical trials and to be able to accurately monitor changes over time. The central autonomic nervous system, which controls the activity of the nerves controlling the function of the heart and lungs, has been shown to function abnormally in Rett syndrome subjects. The abnormalities include irregular breathing patterns, extreme agitation with large pupils and flushed face, vacant spells, abnormal brain wave activity, seizures and poor circulation. A relatively new instrument for evaluating the central autonomic nervous system, the NeuroscopeTM can measure and monitor the activity of the central autonomic nervous system. Information derived from the assessment of the autonomic nervous system will provide a valuable tool for monitoring Rett syndrome patients during clinical treatment studies. The main aim of my study is to establish the methods for assessing and monitoring central autonomic nervous system function in Rett syndrome patients.

 Request for additional information

Top

 
   
©2004 Medifit Instrument Ltd. All Rights Reserved.